Evidence map›Paper›PMID 38632550›Full record

ArticleBMC primary care2024

Statin use for cardiovascular disease prevention: perceptions among people living with HIV in the United States.

Adedotun Ogunbajo, Ivy Todd, Deborah Zajdman, Abraelle Anderson, Soma Wali, Allison Diamant, Joseph A Ladapo, Allison J Ober

Open access · goldAbstract read
In one paragraph

Article in BMC primary care, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 3 citations in OpenAlex.

  1. Trial
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Adedotun OgunbajoRAND Corporation, Arlington, VA, United States of America. dotunogunbajo@gmail.com.
Ivy ToddRAND Corporation, Pittsburgh, PA, United States of America.
Deborah ZajdmanRAND Corporation, Santa Monica, VA, United States of America.
Abraelle AndersonRAND Corporation, Santa Monica, VA, United States of America.
Soma WaliDivision of General Internal Medicine and Health Services Research, Department of Medicine, UCLA Geffen School of Medicine, Los Angeles, CA, United States of America.
Allison DiamantDivision of General Internal Medicine and Health Services Research, Department of Medicine, UCLA Geffen School of Medicine, Los Angeles, CA, United States of America.
Joseph A LadapoDepartment of Medicine, University of Florida College of Medicine, Gainesville, FL, United States of America.
Allison J OberRAND Corporation, Arlington, VA, United States of America.
RAND Corporation · USUniversity of California, Los Angeles · USFlorida College · US

Funding

Behavioral Economics and Implementation Research to Reduce Cardiovascular Risk in HIV-infected AdultsU01HL142104 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DIAMANT, ALLISON LESLIE · 2018 to 2021
$2.7M
Developing and testing a telehealth intervention to increase HIV pre-exposure prophylaxis uptake and adherence among sexual minority men in NigeriaK01MH129165 · NIMH · RAND CORPORATION · PI Adedotun Ogunbajo · 2022 to 2026
$980k
NHLBI NIH HHS U01 HL142104NHLBI NIH HHS U01HL142104NIMH NIH HHS K01 MH129165NIMH NIH HHS MH129165
6 · The paper itself

Abstract

backgroundPeople living with HIV (PLWH) may be at heightened risk for cardiovascular disease (CVD). Statin use and lifestyle changes reduce the risk of CVD but remain under-prescribed among PLWH. The objective of this study was to characterize knowledge of CVD and statin use, current usage, barriers to taking statins, and information desired by PLWH to improve statin uptake among PLWH in Los Angeles, CA.

methodsBetween April 2019 and April 2020, we conducted four focus group discussions (n = 37) with patients across three public community health clinics that serve PLWH in Los Angeles County, California. All clinics participated in a larger study to improve statin prescribing for PLWH. We asked about knowledge of statins, willingness to take a statin, possible barriers to statin usage, preferred information sources for health information, and desired information about statins. We utilized standard qualitative content analysis methods to identify themes.

resultsWe found a range in the awareness of statins, with some participants reporting never having heard of statins while others had a history of statin use. There were concerns about the potential long-term effect of statin use, but participants expressed willingness to use CVD medications generally and statins specifically, especially if recommended by their healthcare provider. Participants also expressed interest in potential alternatives to statin usage such as exercising regularly and nutritious eating.

conclusionsMore interventions are needed to increase statin use among PLWH to improve CVD outcomes, which also has implications for HIV progression. Clinics should aim to increase patient and provider knowledge about CVD risk and statin use for PLWH and provide shared decision-making tools that are easy to use and culturally appropriate.

Indexed as

Cardiovascular DiseasesHIV InfectionsHydroxymethylglutaryl-CoA Reductase InhibitorsHumansLos AngelesUnited StatesHydroxymethylglutaryl-CoA Reductase InhibitorsCardiovascular diseasePeople living with HIVSocial determinants of healthStatin therapy

Identifiers

PMID38632550
PMCPMC11022377
OpenAlexW4394883635

What OpenQuestion holds

Texttitle and abstract
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.